William P. Sheridan
Corporate Officer/Principal bei BIOCRYST PHARMACEUTICALS, INC.
Vermögen: 30 729 $ am 31.03.2024
Profil
William P.
Sheridan's current job is as the Chief Development Officer at BioCryst Pharmaceuticals, Inc. His former job was as the Vice President-North American Medical Affairs at Amgen, Inc. He also served as the Head-Bone Marrow Transplant Service at Royal Melbourne Hospital.
Dr. Sheridan holds a doctorate degree from the University of Melbourne.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.04.2023 | 6 049 ( 0,00% ) | 30 729 $ | 31.03.2024 |
Aktive Positionen von William P. Sheridan
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 15.09.2022 |
Ehemalige bekannte Positionen von William P. Sheridan
| Unternehmen | Position | Ende |
|---|---|---|
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 01.11.2007 |
Royal Melbourne Hospital
 Royal Melbourne Hospital Hospital/Nursing ManagementHealth Services Royal Melbourne Hospital owns and operates a hospital. The private company is based in Parkville, Australia. | Corporate Officer/Principal | - |
Ausbildung von William P. Sheridan
| University of Melbourne | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Royal Melbourne Hospital
Royal Melbourne Hospital Hospital/Nursing ManagementHealth Services Royal Melbourne Hospital owns and operates a hospital. The private company is based in Parkville, Australia. | Health Services |
